Difference between revisions of "Dysplasia-associated lesion or mass"

From Libre Pathology
Jump to navigation Jump to search
(split out)
 
(9 intermediate revisions by the same user not shown)
Line 1: Line 1:
'''Dysplasia-associated lesion or mass''', abbreviated ''DALM'', is a clinico-pathologic diagnosis seen in the context of [[inflammatory bowel disease]].
'''Dysplasia-associated lesion or mass''', abbreviated '''DALM''', was a clinico-pathologic diagnosis rendered in the context of [[inflammatory bowel disease]].
 
''DALM'' is considered an obsolete term.<ref name=pmid29789648>{{cite journal |authors=Chiu K, Riddell RH, Schaeffer DF |title=DALM, rest in peace: a pathologist's perspective on dysplasia in inflammatory bowel disease in the post-DALM era |journal=Mod Pathol |volume=31 |issue=8 |pages=1180–1190 |date=August 2018 |pmid=29789648 |doi=10.1038/s41379-018-0068-9 |url=}}</ref>


==General==
==General==
*Proving invasive malignancy (on histopathologic grounds alone) in the setting of chronic inflammation is difficult.<ref name=pmid7450425>{{Cite journal  | last1 = Blackstone | first1 = MO. | last2 = Riddell | first2 = RH. | last3 = Rogers | first3 = BH. | last4 = Levin | first4 = B. | title = Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. | journal = Gastroenterology | volume = 80 | issue = 2 | pages = 366-74 | month = Feb | year = 1981 | doi =  | PMID = 7450425 }}</ref>
*Proving invasive malignancy (on histopathologic grounds alone) in the setting of chronic inflammation is difficult.<ref name=pmid7450425>{{Cite journal  | last1 = Blackstone | first1 = MO. | last2 = Riddell | first2 = RH. | last3 = Rogers | first3 = BH. | last4 = Levin | first4 = B. | title = Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. | journal = Gastroenterology | volume = 80 | issue = 2 | pages = 366-74 | month = Feb | year = 1981 | doi =  | PMID = 7450425 }}</ref>
*This diagnosis depends on correlation of endoscopy and histopathology - '''important'''.<ref name=pmid21912466>{{Cite journal  | last1 = Neumann | first1 = H. | last2 = Vieth | first2 = M. | last3 = Langner | first3 = C. | last4 = Neurath | first4 = MF. | last5 = Mudter | first5 = J. | title = Cancer risk in IBD: how to diagnose and how to manage DALM and ALM. | journal = World J Gastroenterol | volume = 17 | issue = 27 | pages = 3184-91 | month = Jul | year = 2011 | doi = 10.3748/wjg.v17.i27.3184 | PMID = 21912466 }}</ref>
*The diagnosis depended on correlation of endoscopy and histopathology - '''important'''.<ref name=pmid21912466>{{Cite journal  | last1 = Neumann | first1 = H. | last2 = Vieth | first2 = M. | last3 = Langner | first3 = C. | last4 = Neurath | first4 = MF. | last5 = Mudter | first5 = J. | title = Cancer risk in IBD: how to diagnose and how to manage DALM and ALM. | journal = World J Gastroenterol | volume = 17 | issue = 27 | pages = 3184-91 | month = Jul | year = 2011 | doi = 10.3748/wjg.v17.i27.3184 | PMID = 21912466 }}</ref>
**Biopsies are usually taken of the lesion and around the base.
**Biopsies are usually taken of the lesion and around the base.
*Historically, this diagnosis lead to [[colectomy]].  
*This diagnosis (''DALM'') typically lead to [[colectomy]].  
**It may be managed endoscopically in the context of modern endoscopy.<ref>{{Cite journal  | last1 = East | first1 = JE. | last2 = Toyonaga | first2 = T. | last3 = Suzuki | first3 = N. | title = Endoscopic management of nonpolypoid colorectal lesions in colonic IBD. | journal = Gastrointest Endosc Clin N Am | volume = 24 | issue = 3 | pages = 435-45 | month = Jul | year = 2014 | doi = 10.1016/j.giec.2014.03.003 | PMID = 24975534 }}
**The same histology today (2014) may be managed endoscopically.<ref name=pmid24975534>{{Cite journal  | last1 = East | first1 = JE. | last2 = Toyonaga | first2 = T. | last3 = Suzuki | first3 = N. | title = Endoscopic management of nonpolypoid colorectal lesions in colonic IBD. | journal = Gastrointest Endosc Clin N Am | volume = 24 | issue = 3 | pages = 435-45 | month = Jul | year = 2014 | doi = 10.1016/j.giec.2014.03.003 | PMID = 24975534 }}</ref>
</ref>


==Gross==
==Gross==
Line 25: Line 26:
Image:
Image:
*[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3158393/figure/F7/ DALM (nlm.nih.gov)].<ref name=pmid21912466/>
*[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3158393/figure/F7/ DALM (nlm.nih.gov)].<ref name=pmid21912466/>
==Sign out==
*''DALM'' is considered obsolete; it should ''not'' be used.
*''DALM'' was replaced by ''visible dysplasia''; the endoscopist saw a lesion.
''Visible dysplasia'' is subdivided into:
#Polypoid.
#Non-polypoid.


==See also==
==See also==
*[[Inflammatory bowel disease]].
*[[Inflammatory bowel disease]].
*[[Invisible colonic dysplasia]].


==References==
==References==

Latest revision as of 19:32, 9 March 2021

Dysplasia-associated lesion or mass, abbreviated DALM, was a clinico-pathologic diagnosis rendered in the context of inflammatory bowel disease.

DALM is considered an obsolete term.[1]

General

  • Proving invasive malignancy (on histopathologic grounds alone) in the setting of chronic inflammation is difficult.[2]
  • The diagnosis depended on correlation of endoscopy and histopathology - important.[3]
    • Biopsies are usually taken of the lesion and around the base.
  • This diagnosis (DALM) typically lead to colectomy.
    • The same histology today (2014) may be managed endoscopically.[4]

Gross

  • Endoscopically "suspicious", i.e. endoscopist thinks this is a DALM - essential feature.
    • Usually have a positive lifting sign.

Microscopic

Features:

DDx:

  • Sporadic adenomatous polyp -- favouring sporadic:
    • Sharp transition between lesion and the surrounding tissue.[3]
    • Polyps not at site of active disease.[5]

Image:

Sign out

  • DALM is considered obsolete; it should not be used.
  • DALM was replaced by visible dysplasia; the endoscopist saw a lesion.

Visible dysplasia is subdivided into:

  1. Polypoid.
  2. Non-polypoid.

See also

References

  1. ↑ Chiu K, Riddell RH, Schaeffer DF (August 2018). "DALM, rest in peace: a pathologist's perspective on dysplasia in inflammatory bowel disease in the post-DALM era". Mod Pathol 31 (8): 1180–1190. doi:10.1038/s41379-018-0068-9. PMID 29789648.
  2. ↑ 2.0 2.1 Blackstone, MO.; Riddell, RH.; Rogers, BH.; Levin, B. (Feb 1981). "Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy.". Gastroenterology 80 (2): 366-74. PMID 7450425.
  3. ↑ 3.0 3.1 3.2 Neumann, H.; Vieth, M.; Langner, C.; Neurath, MF.; Mudter, J. (Jul 2011). "Cancer risk in IBD: how to diagnose and how to manage DALM and ALM.". World J Gastroenterol 17 (27): 3184-91. doi:10.3748/wjg.v17.i27.3184. PMID 21912466.
  4. ↑ East, JE.; Toyonaga, T.; Suzuki, N. (Jul 2014). "Endoscopic management of nonpolypoid colorectal lesions in colonic IBD.". Gastrointest Endosc Clin N Am 24 (3): 435-45. doi:10.1016/j.giec.2014.03.003. PMID 24975534.
  5. ↑ Fogt, F.; Urbanski, SJ.; Sanders, ME.; Furth, EE.; Zimmerman, RL.; Deren, JJ.; Noffsinger, AE.; Vortmeyer, AO. et al. (Mar 2000). "Distinction between dysplasia-associated lesion or mass (DALM) and adenoma in patients with ulcerative colitis.". Hum Pathol 31 (3): 288-91. PMID 10746669.
Retrieved from "https://librepathology.org/w/index.php?title=Dysplasia-associated_lesion_or_mass&oldid=51191"